Suppr超能文献

IgG4 相关疾病的终身过敏症状:病例对照研究。

Lifetime Allergy Symptoms in IgG4-Related Disease: A Case-Control Study.

机构信息

Harvard Medical School, Boston, Massachusetts.

Massachusetts General Hospital, Boston.

出版信息

Arthritis Care Res (Hoboken). 2022 Jul;74(7):1188-1195. doi: 10.1002/acr.24545. Epub 2022 Apr 6.

Abstract

OBJECTIVE

The etiology of IgG4-related disease (IgG4-RD) is unknown, and there has been controversy over the significance of allergic conditions in IgG4-RD. We examined the prevalence of lifetime allergy symptoms in IgG4-RD and the association between these and IgG4-RD.

METHODS

We identified IgG4-RD patients and non-IgG4-RD controls without autoimmune conditions seen at a single center. IgG4-RD patients were classified using the American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria. Allergy symptoms were ascertained by questionnaire. We assessed the association of IgG4-RD features with allergy symptoms. We compared the proportion of cases and controls with allergy symptoms using conditional logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (95% CIs) after matching cases and controls 1:1 by age and sex.

RESULTS

Lifetime allergy symptoms were reported by 165 (71%) of 231 IgG4-RD patients. Aeroallergen symptoms were most commonly reported (n = 135, 58%), followed by skin allergy symptoms (n = 97, 42%) and food allergy symptoms (n = 47, 20%). IgG4-RD cases with a history of allergy symptoms were more likely to have head and neck involvement (OR 2.0 [95% CI 1.1-3.6]) and peripheral eosinophilia (OR 3.3 [95% CI 1.2-9.0]) than those without allergy symptoms. The prevalence of any allergy symptoms was similar between cases and controls (OR 0.7 [95% CI 0.4-1.1]); this remained consistent after stratifying by head and neck involvement.

CONCLUSION

Lifetime allergy symptoms are common in IgG4-RD but are not reported more often in IgG4-RD compared to non-IgG4-RD patients without autoimmune conditions. These findings suggest that allergies are not uniquely associated with the pathogenesis or presentation of IgG4-RD.

摘要

目的

IgG4 相关疾病(IgG4-RD)的病因尚不清楚,过敏状态在 IgG4-RD 中的意义存在争议。我们研究了 IgG4-RD 患者一生中过敏症状的患病率,以及这些症状与 IgG4-RD 之间的关联。

方法

我们在一个单中心确定了 IgG4-RD 患者和无自身免疫性疾病的非 IgG4-RD 对照。采用美国风湿病学会/欧洲抗风湿病联盟分类标准对 IgG4-RD 患者进行分类。通过问卷确定过敏症状。我们评估了 IgG4-RD 特征与过敏症状的关系。我们通过年龄和性别 1:1 匹配病例和对照后,使用条件逻辑回归比较病例和对照中具有过敏症状的比例,以估计比值比(OR)和 95%置信区间(95%CI)。

结果

231 例 IgG4-RD 患者中,165 例(71%)报告有一生中的过敏症状。最常见的是气传过敏原症状(n=135,58%),其次是皮肤过敏症状(n=97,42%)和食物过敏症状(n=47,20%)。有过敏症状史的 IgG4-RD 病例更有可能出现头颈部受累(OR 2.0[95%CI 1.1-3.6])和外周血嗜酸性粒细胞增多(OR 3.3[95%CI 1.2-9.0]),而无过敏症状者则较少。病例和对照之间任何过敏症状的患病率相似(OR 0.7[95%CI 0.4-1.1]);在头颈部受累分层后仍然一致。

结论

一生中的过敏症状在 IgG4-RD 中很常见,但与无自身免疫性疾病的非 IgG4-RD 患者相比,在 IgG4-RD 中并不更常见。这些发现表明,过敏与 IgG4-RD 的发病机制或表现无关。

相似文献

1
Lifetime Allergy Symptoms in IgG4-Related Disease: A Case-Control Study.IgG4 相关疾病的终身过敏症状:病例对照研究。
Arthritis Care Res (Hoboken). 2022 Jul;74(7):1188-1195. doi: 10.1002/acr.24545. Epub 2022 Apr 6.

引用本文的文献

1
Current and future advances in practice: IgG4-related disease.实践中的当前及未来进展:IgG4相关性疾病
Rheumatol Adv Pract. 2024 Apr 10;8(2):rkae020. doi: 10.1093/rap/rkae020. eCollection 2024.
3
IgG4-related diseases involving pleura: a case report and literature review.IgG4相关性胸膜疾病:一例报告及文献复习
Front Med (Lausanne). 2023 Nov 27;10:1247884. doi: 10.3389/fmed.2023.1247884. eCollection 2023.
5
Implication of allergy and atopy in IgG4-related disease.过敏和特应性在IgG4相关疾病中的意义。
World Allergy Organ J. 2023 Apr 17;16(4):100765. doi: 10.1016/j.waojou.2023.100765. eCollection 2023 Apr.

本文引用的文献

1
IgG4-related disease and allergen-specific immunotherapy.IgG4相关性疾病与变应原特异性免疫治疗
Ann Allergy Asthma Immunol. 2020 Jun;124(6):631-633. doi: 10.1016/j.anai.2020.03.024. Epub 2020 Mar 30.
9
Analysis of allergic reaction in IgG4-related disease.IgG4相关疾病中过敏反应的分析。
Mod Rheumatol. 2019 Nov;29(6):1063-1065. doi: 10.1080/14397595.2019.1572488. Epub 2019 Feb 18.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验